PEP is a Phase II certified NMTTM site. This designation is the result of years of an intensive certification process and thousands of personnel hours dedicated to mastering the core concepts and implementation of the Neurosequential Model of TherapeuticsTM.
The Neurosequential Model of Therapeutics (NMT)TM is a developmentally sensitive, neurobiology-informed approach to clinical problem solving. It is not a specific therapeutic technique of intervention. It is an approach that integrates core principles of neurodevelopment and traumatology to inform work with children, families and the communities in which they live. The Neurosequential approach has three key components: training/capacity building, assessment and then, the specific recommendations for the selection and sequencing of therapeutic, educational and enrichment activities that match the needs and strengths of the individual.